Q3 2022 13F Holders as of 30 Sep 2022
-
Type / Class
-
Equity / Common Stock, $0.001 par value per share
-
Shares outstanding
-
57,056,058
-
Number of holders
-
41
-
Total 13F shares, excl. options
-
9,828,525
-
Shares change
-
+4,096,128
-
Total reported value, excl. options
-
$88,847,076
-
Value change
-
+$41,623,406
-
Number of buys
-
26
-
Number of sells
-
-8
-
Price
-
$9.04
Significant Holders of Astria Therapeutics, Inc. - Common Stock, $0.001 par value per share (ATXS) as of Q3 2022
45 filings reported holding ATXS - Astria Therapeutics, Inc. - Common Stock, $0.001 par value per share as of Q3 2022.
Astria Therapeutics, Inc. - Common Stock, $0.001 par value per share (ATXS) has 41 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 9,828,525 shares
of 57,056,058 outstanding shares and own 17% of the company stock.
Largest 10 shareholders include PERCEPTIVE ADVISORS LLC (1,281,197 shares), Cormorant Asset Management, LP (1,200,000 shares), Vivo Capital, LLC (1,000,000 shares), Fairmount Funds Management LLC (911,736 shares), Ikarian Capital, LLC (699,440 shares), DRIEHAUS CAPITAL MANAGEMENT LLC (656,361 shares), Tri Locum Partners LP (631,579 shares), VANGUARD GROUP INC (531,153 shares), Ghost Tree Capital, LLC (500,000 shares), and Altium Capital Management LP (445,000 shares).
This table shows the top 41 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.